acadia healthcare co inc - ACHC

ACHC

Close Chg Chg %
11.73 0.18 1.53%

Closed Market

11.91

+0.18 (1.53%)

Volume: 2.64M

Last Updated:

Jan 15, 2026, 4:00 PM EDT

Company Overview: acadia healthcare co inc - ACHC

ACHC Key Data

Open

$11.68

Day Range

11.43 - 11.99

52 Week Range

11.60 - 45.61

Market Cap

$1.08B

Shares Outstanding

92.26M

Public Float

89.34M

Beta

0.88

Rev. Per Employee

N/A

P/E Ratio

10.65

EPS

$1.18

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

2.59M

 

ACHC Performance

1 Week
 
-11.97%
 
1 Month
 
-17.35%
 
3 Months
 
-50.71%
 
1 Year
 
-72.80%
 
5 Years
 
-76.53%
 

ACHC Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 14
Full Ratings ➔

About acadia healthcare co inc - ACHC

Acadia Healthcare Co., Inc. engages in the provision of behavioral healthcare services across the United States. The firm provides services to its patients in a variety of settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, and outpatient clinics. The company was founded in January 2005 and is headquartered in Franklin, TN.

ACHC At a Glance

Acadia Healthcare Co., Inc.
4020 Aspen Grove Drive
Franklin, Tennessee 37067
Phone 1-615-861-6000 Revenue 3.15B
Industry Medical/Nursing Services Net Income 255.61M
Sector Health Services 2024 Sales Growth 7.69%
Fiscal Year-end 12 / 2025 Employees 25,500
View SEC Filings

ACHC Valuation

P/E Current 10.646
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 14.28
Price to Sales Ratio 1.157
Price to Book Ratio 1.184
Price to Cash Flow Ratio 28.14
Enterprise Value to EBITDA 8.613
Enterprise Value to Sales 1.835
Total Debt to Enterprise Value 0.362

ACHC Efficiency

Revenue/Employee 123,684.824
Income Per Employee 10,024.00
Receivables Turnover 7.474
Total Asset Turnover 0.557

ACHC Liquidity

Current Ratio 0.999
Quick Ratio 0.989
Cash Ratio 0.132

ACHC Profitability

Gross Margin 22.574
Operating Margin 16.559
Pretax Margin 10.84
Net Margin 8.104
Return on Assets 4.518
Return on Equity 8.73
Return on Total Capital 4.944
Return on Invested Capital 5.495

ACHC Capital Structure

Total Debt to Total Equity 68.194
Total Debt to Total Capital 40.545
Total Debt to Total Assets 35.188
Long-Term Debt to Equity 64.831
Long-Term Debt to Total Capital 38.545
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Acadia Healthcare Co Inc - ACHC

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
2.31B 2.61B 2.93B 3.15B
Sales Growth
+10.74% +12.79% +12.20% +7.69%
Cost of Goods Sold (COGS) incl D&A
1.78B 2.01B 2.25B 2.44B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
106.72M 117.77M 132.35M 149.59M
Depreciation
106.72M 117.77M 132.35M 149.59M
Amortization of Intangibles
- - - -
-
COGS Growth
+8.82% +12.64% +11.96% +8.72%
Gross Income
533.31M 604.26M 682.61M 711.98M
Gross Income Growth
+17.66% +13.30% +12.97% +4.30%
Gross Profit Margin
+23.04% +23.15% +23.31% +22.57%
2021 2022 2023 2024 5-year trend
SG&A Expense
136.74M 158.01M 176.01M 189.71M
Research & Development
- - - -
-
Other SG&A
136.74M 158.01M 176.01M 189.71M
SGA Growth
+13.49% +15.56% +11.39% +7.78%
Other Operating Expense
- - - -
-
Unusual Expense
43.82M 2.34M 459.58M 64.03M
EBIT after Unusual Expense
352.75M 443.90M 47.02M 458.25M
Non Operating Income/Expense
- - - 9.75M
-
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
76.99M 69.76M 82.13M 116.37M
Interest Expense Growth
-51.30% -9.39% +17.73% +41.70%
Gross Interest Expense
76.99M 69.76M 82.13M 116.37M
Interest Capitalized
- - - -
-
Pretax Income
275.76M 374.14M (25.36M) 341.88M
Pretax Income Growth
+50.04% +35.68% -106.78% +1,448.10%
Pretax Margin
+11.91% +14.33% -0.87% +10.84%
Income Tax
67.56M 94.11M (9.70M) 77.39M
Income Tax - Current - Domestic
55.01M 76.81M 83.35M 9.06M
Income Tax - Current - Foreign
778.00K 755.00K 933.00K 622.00K
Income Tax - Deferred - Domestic
11.45M 16.18M (94.54M) 67.34M
Income Tax - Deferred - Foreign
325.00K 360.00K 557.00K 368.00K
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
208.20M 280.03M (15.66M) 264.48M
Minority Interest Expense
4.93M 6.89M 6.01M 8.87M
Net Income
203.28M 273.14M (21.67M) 255.61M
Net Income Growth
+44.93% +34.37% -107.93% +1,279.73%
Net Margin Growth
+8.78% +10.46% -0.74% +8.10%
Extraordinaries & Discontinued Operations
- - - 849.00K
-
Discontinued Operations
- - - 849.00K
-
Net Income After Extraordinaries
204.13M 273.14M (21.67M) 255.61M
Preferred Dividends
- - - -
-
Net Income Available to Common
204.13M 273.14M (21.67M) 255.61M
EPS (Basic)
2.2995 3.0457 -0.2382 2.7899
EPS (Basic) Growth
+3.53% +32.45% -107.82% +1,271.24%
Basic Shares Outstanding
88.77M 89.68M 90.95M 91.62M
EPS (Diluted)
2.2482 2.9833 -0.2382 2.7766
EPS (Diluted) Growth
+2.04% +32.70% -107.98% +1,265.66%
Diluted Shares Outstanding
90.79M 91.56M 90.95M 92.06M
EBITDA
503.29M 564.01M 638.95M 671.87M
EBITDA Growth
+17.58% +12.06% +13.29% +5.15%
EBITDA Margin
+21.75% +21.61% +21.82% +21.30%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 20.786
Number of Ratings 14 Current Quarters Estimate 0.317
FY Report Date 03 / 2026 Current Year's Estimate 1.92
Last Quarter’s Earnings 0.012 Median PE on CY Estimate N/A
Year Ago Earnings 2.075 Next Fiscal Year Estimate 2.064
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 10 10 13 9
Mean Estimate 0.32 0.67 1.92 2.06
High Estimates 0.46 0.90 2.40 2.71
Low Estimate 0.19 0.38 1.48 1.50
Coefficient of Variance 26.70 24.10 14.25 19.33

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 7 7 8
OVERWEIGHT 1 1 1
HOLD 5 6 6
UNDERWEIGHT 1 1 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Acadia Healthcare Co Inc - ACHC

Date Name Shares Transaction Value
Oct 3, 2025 Nasser Khan Chief Operating Officer 55,023 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $24.54 per share 1,350,264.42
Mar 3, 2025 Christopher H. Hunter Chief Executive Officer; Director 136,632 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 3, 2025 Christopher H. Hunter Chief Executive Officer; Director 149,756 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 3, 2025 Christopher H. Hunter Chief Executive Officer; Director 132,761 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $40.26 per share 5,344,957.86
Mar 3, 2025 Brian P. Farley EVP, GC and Secretary 34,416 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 3, 2025 Heather Dixon Chief Financial Officer 78,676 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Acadia Healthcare Co Inc in the News